RPTX - Repare Therapeutics GAAP EPS of -$0.75 misses by $0.02 revenue of $18.2M beats by $9.87M February, 28 2023 05:41 PM Repare Therapeutics Inc. Repare Therapeutics press release ( NASDAQ: RPTX ): Q4 GAAP EPS of -$0.75 misses by $0.02 . Revenue of $18.2M (+164.5% Y/Y) beats by $9.87M . For further details see: Repare Therapeutics GAAP EPS of -$0.75 misses by $0.02, revenue of $18.2M beats by $9.87M